Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 165 Breast Neoplasms 163 Carcinoma, Non-Small-Cell Lung 143 Colorectal Neoplasms 101 Prostatic Neoplasms 99 Lung Neoplasms 86 Ovarian Neoplasms 78 Neoplasm Metastasis 72 Multiple Myeloma 71 Pancreatic Neoplasms 67 Leukemia, Myeloid, Acute 59 Endometrial Neoplasms 47 Squamous Cell Carcinoma of Head and Neck 44 Lymphoma 42 Stomach Neoplasms 41 Recurrence 40 Melanoma 39 Glioblastoma 39 Carcinoma, Renal Cell 39 Brain Neoplasms 39 Carcinoma, Hepatocellular 38 Urinary Bladder Neoplasms 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 37 Lymphoma, Non-Hodgkin 34 Leukemia, Lymphocytic, Chronic, B-Cell 34 Hematologic Neoplasms 34 Glioma 34 Sarcoma 33 Esophageal Neoplasms 31 Small Cell Lung Carcinoma 30

Interventions

lutetium Lu 177 dotatate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Disease Progression × 30 days × Clear all

NCT04954820 2026-06-04

ReLUTH

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2 Recruiting

Neuroendocrine Tumors, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡